ctDNA in Gastric and Gastroesophageal Cancer: Prognostic, Predictive, or Preliminary?
- PMID: 31582518
- DOI: 10.1158/1078-0432.CCR-19-2774
ctDNA in Gastric and Gastroesophageal Cancer: Prognostic, Predictive, or Preliminary?
Abstract
In gastric and gastroesophageal adenocarcinoma, circulating tumor DNA identifies molecular drivers missed using routine tumor biopsy, can refine patient selection for targeted therapy, and may be prognostic following surgical resection. However, lack of standardization could impede adoption of this technology as a clinically useful tool; prospective validation in clinical trials is required.See related article by Maron et al., p. 7098.
©2019 American Association for Cancer Research.
Comment on
-
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.Clin Cancer Res. 2019 Dec 1;25(23):7098-7112. doi: 10.1158/1078-0432.CCR-19-1704. Epub 2019 Aug 19. Clin Cancer Res. 2019. PMID: 31427281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
